Intralytix Receives Multimillion-Dollar Clinical Trial Award From NIAID to Manage Shigella Infections in Humans COLUMBIA, Md., May 4, 2020 Intralytix,…
ROCKVILLE, Md.--(BUSINESS WIRE)--May 5, 2020-- Immunomic Therapeutics, Inc., (“ITI”) a privately-held clinical-stage biotechnology company pioneering the study of nucleic acid…